Calliditas Therapeutics’ nomination committee for the AGM 2021
Calliditas Therapeutics AB (publ.) publishes the nomination committee’s composition for the AGM in 2021.The nomination committee, which is appointed in accordance with the principles adopted by the extraordinary general meeting on September 14, 2017, consists of: • Patrick Sobocki, appointed by Stiftelsen Industrifonden • Spike Loy, appointed by BVF • Karl Tobieson, appointed by Linc AB • Elmar Schnee (chairman of the board of directors) The nomination committee shall, before the annual general meeting 2021, prepare a proposal for the election of chairman and other members of